Xenotransplantation - 2000

被引：13

作者：

Goddard, MJ ^{[1
]}

Foweraker, JE

Wallwork, J

机构：

[1] Papworth Hosp, Dept Histopathol, Cambridge CB3 8RE, England

[2] Papworth Hosp, Dept Microbiol, Cambridge, England

[3] Papworth Hosp, Dept Transplant Surg, Cambridge, England

来源：

JOURNAL OF CLINICAL PATHOLOGY | 2000年 / 53卷 / 01期

关键词：

D O I：

10.1136/jcp.53.1.44

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

[No abstract available]

引用

页码：44 / 48

页数：5

共 57 条

[1] CELLULAR BASIS OF THE PROLIFERATIVE RESPONSE OF HUMAN T-CELLS TO MOUSE XENOANTIGENS [J].

ALTER, BJ ;

BACH, FH .

JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) :333-338

[2] Uncertainty in xenotransplantation: Individual benefit versus collective risk [J].

Bach, FH ;

Fishman, JA ;

Daniels, N ;

Proimos, J ;

Anderson, B ;

Carpenter, CB ;

Forrow, L ;

Robson, SC ;

Fineberg, HV .

NATURE MEDICINE, 1998, 4 (02) :141-144

[3] COXSACKIEVIRUS B3 ADAPTED TO GROWTH IN RD CELLS BINDS TO DECAY-ACCELERATING FACTOR (CD55) [J].

BERGELSON, JM ;

MOHANTY, JG ;

CROWELL, RL ;

JOHN, NFS ;

LUBLIN, DM ;

FINBERG, RW .

JOURNAL OF VIROLOGY, 1995, 69 (03) :1903-1906

[4] DECAY-ACCELERATING FACTOR (CD55), A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED COMPLEMENT REGULATORY PROTEIN, IS A RECEPTOR FOR SEVERAL ECHOVIRUSES [J].

BERGELSON, JM ;

CHAN, M ;

SOLOMON, KR ;

STJOHN, NF ;

LIN, HM ;

FINBERG, RW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6245-6248

[5] ACTIVATION OF INTRAGRAFT ENDOTHELIAL AND MONONUCLEAR-CELLS DURING DISCORDANT XENOGRAFT REJECTION [J].

BLAKELY, ML ;

VANDERWERF, WJ ;

BERNDT, MC ;

DALMASSO, AP ;

BACH, FH ;

HANCOCK, WW .

TRANSPLANTATION, 1994, 58 (10) :1059-1066

[6]

Borie DC, 1998, INFECT CONT HOSP EP, V19, P355

[7] Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage [J].

Byrne, G ;

McCurry, KR ;

Martin, MJ ;

McClellan, SM ;

Platt, JL ;

Logan, JS .

TRANSPLANTATION, 1997, 63 (01) :149-155

[8] Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival [J].

Candinas, D ;

Lesnikoski, BA ;

Robson, SC ;

Miyatake, T ;

Scesney, SM ;

Marsh, HC ;

Ryan, US ;

Dalmasso, AP ;

Hancock, WW ;

Bach, FH .

TRANSPLANTATION, 1996, 62 (03) :336-342

[9] T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection [J].

Candinas, D ;

Belliveau, S ;

Koyamada, N ;

Miyatake, T ;

Hechenleitner, P ;

Mark, W ;

Bach, FH ;

Hancock, WW .

TRANSPLANTATION, 1996, 62 (12) :1920-1927

[10]

Centers for Disease Control and Prevention, 1999, MMWR MORB MORTAL WKL, V48, P265

← 1 2 3 4 5 6 →